A key factor driving the growth of the global phosphoinositide 3-Kinase (PI3K) inhibitors market size is recent approvals from regulatory bodies. Although many approved therapies are available for various types of blood cancer, the market still witnesses a huge unmet need. Chemotherapies are widely used for the treatment of several types of cancer, including lymphomas. However, chemotherapies have some limitations, which reduces patient adherence toward the treatment. Such factors have fueled exhaustive research on target therapies such as PI3K inhibitors for the treatment of cancer. Several drugs have been approved, such as copanlisib (ALIQOPA) for the treatment of FL, in September 2017. Thus, recent approvals are expected to fuel the PI3K inhibitors market growth during the forecast period.

As per Technavio, the reimbursement programs will have a positive impact on the market and contribute to its growth significantly over the forecast period. This global phosphoinositide 3-Kinase (PI3K) inhibitors market 2019-2023 research report also analyzes other important trends and market drivers that will affect market growth over 2019-2023.

Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Market: Reimbursement Programs

The cost of PI3K inhibitors is usually high, owing to the complex manufacturing process. This has also had a negative impact on the PI3K inhibitors market for a long time. Therefore, various government bodies have started patient assistance programs to reduce the cost burden on patients and make these treatments available at an affordable price. Thus, the availability of reimbursement programs is expected to fuel the growth of the PI3K inhibitors market size during the forecast period.

“Apart from the availability of reimbursement programs, other factors such as the growing awareness about cancer, and the expansion of research indications will have a significant impact on the phosphoinositide 3-Kinase (PI3K) inhibitors market growth during the forecast period,” says a senior analyst at Technavio.

Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Market: Segmentation Analysis

This market research report segments the global phosphoinositide 3-Kinase (PI3K) inhibitors market by application (CLL, FL, and other indications) and geographic regions (North America, Europe, Asia, and ROW).

The North American region led the phosphoinositide 3-Kinase (PI3K) inhibitors market in 2018, followed by Europe, Asia and ROW respectively. The growth of the PI3K inhibitors market in North America can be attributed to the increasing sales of PI3K inhibitors, and the increasing prevalence of several cancer indications, including CLL, FL, and breast cancer.

Technavio’s sample reports are free of charge and contain multiple sections of the report such as the market size and forecast, drivers, challenges, trends, and more.

Some of the key topics covered in the report include:

Market Landscape

Market ecosystem
Market characteristics
Market segmentation analysis
Market Sizing

Market definition
Market size and forecast
Five Forces Analysis

Market Segmentation

Geographical Segmentation

Regional comparison
Key leading countries
Market Drivers

Market Challenges

Market Trends

Vendor Landscape

Vendors covered
Vendor classification
Market positioning of vendors
Competitive scenario
About Technavio

Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavio’s report library consists of more than 10,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

If you are interested in more information, please contact our media team at [email protected].



Contacts
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
www.technavio.com